A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC
Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
This is a perspective, multicenter,randomized controlled trial to evaluate the efficacy and
safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with
locally advanced squamous cell esophageal carcinoma . Analyses of primary objective (ORR)
will be done as defined in the protocol.